+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Ureteroscopy Market Report and Forecast 2024-2032

  • PDF Icon

    Report

  • 200 Pages
  • August 2024
  • Region: Global
  • Expert Market Research
  • ID: 5960397
The global ureteroscopy market was valued at USD 1.05 billion in 2023. It is expected to grow at a CAGR of 5.1% during the forecast period of 2024-2032 and attain a value of USD 1.64 billion by 2032. The market is driven by increasing prevalence of urinary tract stones and rising preference for minimally invasive surgeries across the globe.

Global Ureteroscopy Market Analysis

Ureteroscopy is a minimally invasive procedure used to diagnose and treat conditions affecting the urinary tract, particularly the ureters and kidneys. Utilising a ureteroscope, a thin, flexible instrument equipped with a camera and tools, urologists can visually inspect the ureters and perform various interventions such as stone removal, biopsy, and the treatment of strictures or tumours. The global ureteroscopy market has been witnessing significant growth due to the rising prevalence of urological disorders, advancements in ureteroscopy technology, and increasing demand for minimally invasive surgical procedures.

Market Drivers

  • Rising Prevalence of Urological Disorders: The increasing incidence of kidney stones, ureteral strictures, and urinary tract infections drives the demand for ureteroscopy procedures. Lifestyle changes, dietary habits, and an ageing population contribute to the growing number of urological conditions, necessitating effective diagnostic and therapeutic options.
  • Technological Advancements: Innovations in ureteroscopy equipment, such as the development of flexible and digital ureteroscopes, have enhanced the precision and efficacy of procedures. High-definition imaging and improved manoeuvrability allow for better visualisation and treatment of urological conditions, boosting the adoption of ureteroscopy.
  • Preference for Minimally Invasive Procedures: Minimally invasive techniques like ureteroscopy offer several benefits over traditional open surgeries, including reduced recovery times, lower risk of complications, and shorter hospital stays. Patients and healthcare providers increasingly prefer these advantages, driving the market's growth.
  • Increasing Healthcare Expenditure: Growing investments in healthcare infrastructure, particularly in emerging economies, have expanded access to advanced medical technologies. This trend supports the uptake of ureteroscopy procedures and equipment, contributing to market expansion.

Challenges

  • High Cost of Equipment: Ureteroscopy equipment, including ureteroscopes and associated accessories, can be expensive. The high cost may limit adoption, particularly in low-income regions or healthcare facilities with budget constraints.
  • Lack of Skilled Professionals: Performing ureteroscopy requires specialised training and expertise. A shortage of skilled urologists and trained healthcare personnel in certain regions can hinder the market's growth, as effective treatment outcomes depend on the proficiency of the operator.
  • Risk of Complications: Despite being minimally invasive, ureteroscopy procedures carry risks such as infection, bleeding, and ureteral injury. These potential complications may deter patients and healthcare providers from opting for ureteroscopy, especially when alternative treatment options are available.

Future Opportunities

  • Expansion in Emerging Markets: Rapid urbanisation, increasing healthcare awareness, and improving economic conditions in emerging markets present significant growth opportunities for the ureteroscopy market. Companies can expand their presence in these regions by offering cost-effective and innovative solutions tailored to local needs.
  • Integration of Artificial Intelligence (AI): The incorporation of AI and machine learning in ureteroscopy procedures can enhance diagnostic accuracy and treatment outcomes. AI-powered tools can assist in real-time image analysis, predictive analytics, and decision-making, improving the efficiency and effectiveness of ureteroscopy.
  • Development of Disposable Ureteroscopes: To address the challenges of equipment cost and infection risk, the development and adoption of single-use, disposable ureteroscopes are gaining traction. These devices eliminate the need for sterilisation, reduce the risk of cross-contamination, and can be more cost-effective in the long run.
  • Telemedicine and Remote Assistance: The growing acceptance of telemedicine can facilitate remote consultations and support for ureteroscopy procedures. Expert urologists can provide guidance and oversight to less experienced practitioners in real-time, improving access to specialised care and enhancing procedural outcomes.

Global Ureteroscopy Market Trends

Ureteroscopy is a pivotal procedure in the management of urological disorders, offering minimally invasive solutions for diagnosing and treating conditions affecting the urinary tract. The global ureteroscopy market is evolving rapidly, driven by technological advancements and increasing demand for efficient, patient-friendly medical interventions.

Market Trends

  • Technological Integration: The ureteroscopy market is witnessing significant advancements in technology, with the integration of high-definition imaging, digital ureteroscopes, and laser lithotripsy tools. These innovations enhance procedural accuracy, reduce operation times, and improve patient outcomes. Manufacturers are focusing on developing flexible and durable ureteroscopes to cater to the growing demand for precision and reliability in urological procedures.
  • Rise of Single-Use Ureteroscopes: To address the challenges of cross-contamination and equipment sterilisation, the market is seeing a shift towards single-use, disposable ureteroscopes. These devices offer a cost-effective and convenient alternative, particularly in regions with limited access to advanced sterilisation facilities. The adoption of disposable ureteroscopes is expected to grow, driven by their potential to reduce infection rates and streamline operational workflows.
  • AI and Robotics Integration: The incorporation of artificial intelligence (AI) and robotic assistance in ureteroscopy procedures is an emerging trend. AI-powered tools can assist in real-time image analysis, enhancing diagnostic accuracy and treatment planning. Robotic systems improve the precision and control of surgical instruments, making complex procedures more manageable and reducing the risk of human error.
  • Growing Preference for Minimally Invasive Techniques: Patients and healthcare providers are increasingly favouring minimally invasive procedures due to their numerous benefits, including reduced pain, shorter recovery times, and minimal scarring. Ureteroscopy, being a minimally invasive technique, is gaining traction as a preferred choice for treating various urological conditions. This trend is expected to continue, bolstering market growth.
  • Telemedicine and Remote Assistance: The advent of telemedicine is revolutionising the healthcare landscape, including the field of ureteroscopy. Remote consultations and tele-mentoring are becoming more prevalent, allowing urologists to provide expert guidance and support to practitioners performing ureteroscopy procedures in real-time. This trend enhances access to specialised care, particularly in remote or underserved regions.
  • Expansion in Emerging Markets: The ureteroscopy market is experiencing significant growth in emerging economies due to improving healthcare infrastructure, rising awareness of urological health, and increasing disposable incomes. Companies are investing in these regions, offering cost-effective and innovative ureteroscopy solutions tailored to local healthcare needs. This expansion is expected to drive market growth and create new opportunities for stakeholders.

Global Ureteroscopy Market Segmentation

Market Breakup by Type

  • Flexible Ureteroscopes
  • Semi-rigid Ureteroscopes
  • Rigid Ureteroscopes
The global ureteroscopy market, segmented by type into flexible, semi-rigid, and rigid ureteroscopes, is driven by technological advancements and the rising prevalence of urological disorders. Flexible ureteroscopes, offering superior manoeuvrability and patient comfort, dominate the market. Semi-rigid and rigid ureteroscopes are also crucial for specific diagnostic and therapeutic applications. Future growth is expected to be propelled by increasing demand for minimally invasive procedures, technological integration such as high-definition imaging and AI, and the rising adoption of single-use devices. These segments collectively are poised to drive market expansion, meeting the evolving needs of urologists and patients alike during the forecast period.

Market Breakup by Application

  • Kidney Cancer
  • Urolithiasis
  • Urinary Stricture
  • Others
The global ureteroscopy market, segmented by application into kidney cancer, urolithiasis, urinary stricture, and others, is driven by the increasing prevalence of urological conditions and the growing preference for minimally invasive procedures. Urolithiasis dominates the market due to the high incidence of kidney stones requiring ureteroscopic intervention. Applications in kidney cancer and urinary stricture management also contribute significantly, supported by advancements in ureteroscopy technology. Future growth is anticipated from rising healthcare expenditures, technological innovations, and expanding applications in diagnosing and treating various urological disorders. These segments are poised to drive substantial market growth during the forecast period, enhancing patient outcomes.

Market Breakup by End User

  • Hospitals
  • Specialty Clinics
  • Ambulatory Surgery Centers
  • Others
The global ureteroscopy market, segmented by end user into hospitals, specialty clinics, ambulatory surgery centres, and others, is driven by the increasing demand for advanced urological procedures and the rising incidence of urinary tract disorders. Hospitals hold the largest market share due to their comprehensive facilities and access to advanced ureteroscopy equipment. Specialty clinics and ambulatory surgery centres are experiencing growth owing to their focus on minimally invasive procedures and patient convenience. Future growth is expected to be fuelled by advancements in ureteroscopy technology, increasing healthcare expenditures, and the rising preference for outpatient surgical procedures. These segments collectively are poised to drive significant market expansion during the forecast period.

Market Breakup by Region

  • North America
  • Europe
  • Asia Pacific
  • Latin America
  • Middle East and Africa
The global ureteroscopy market, segmented by region into North America, Europe, Asia Pacific, Latin America, and the Middle East and Africa, is experiencing robust growth driven by technological advancements and rising healthcare expenditures. North America and Europe dominate the market due to their advanced healthcare infrastructure and high prevalence of urological disorders. The Asia Pacific region is poised for rapid growth, fuelled by increasing awareness, improving healthcare facilities, and rising incidences of kidney stones. Latin America and the Middle East and Africa are also witnessing gradual growth due to expanding healthcare access. These regional segments are collectively set to drive substantial market growth in the forecast period.

Global Ureteroscopy Market Competitive Landscape

The global ureteroscopy market is highly competitive, with key players including Storz Medical AG, Boston Scientific Corporation, Elmed Medical Systems, Rocamed, Olympus Corporation, OTU Medical Inc., Cook Medical, Accel Medical, and Stryker. These companies are actively engaged in mergers and acquisitions to expand their market presence and enhance their product portfolios. Research initiatives focus on advancing ureteroscopy technology, improving imaging capabilities, and developing single-use devices. Frequent product introductions aim to address the growing demand for minimally invasive procedures. Strategic partnerships and collaborations are also common, facilitating technological innovation and expanding market reach. Collectively, these activities contribute to the dynamic growth and competitive nature of the ureteroscopy market.

Key Questions Answered in the Report

  • What is the current and future performance of the ureteroscopy market?
  • What are the main challenges facing the ureteroscopy market?
  • What are the key drivers of the ureteroscopy market?
  • What emerging trends are shaping the future of the ureteroscopy market?
  • What factors are expected to propel future growth in the ureteroscopy market?
  • What factors are anticipated to drive future growth in the ureteroscopy market?
  • What is driving growth in specialty clinics and ambulatory surgery centres within the ureteroscopy market?
  • Why do North America and Europe dominate the ureteroscopy market?
  • What are the common strategies used by key players in the ureteroscopy market?

Key Benefits for Stakeholders

  • The industry report offers a comprehensive quantitative analysis of various market segments, historical and current market trends, market forecasts, and dynamics of the global ureteroscopy market from 2017-2032.
  • The research report provides the latest information on the market drivers, challenges, and opportunities in the ureteroscopy market.
  • The study maps the leading, as well as the fastest-growing, regional markets. It further enables stakeholders to identify the key country-level markets within each region.
  • Porter's five forces analysis assists stakeholders in assessing the impact of new entrants, competitive rivalry, supplier power, buyer power, and the threat of substitution. It helps stakeholders to analyze the level of competition within the ureteroscopy industry and its attractiveness.
  • The competitive landscape allows stakeholders to understand their competitive environment and provides insight into the current positions of key players in the market.


This product will be delivered within 5-7 business days.

Table of Contents

1 Preface
1.1 Objectives of the Study
1.2 Key Assumptions
1.3 Report Coverage - Key Segmentation and Scope
1.4 Research Methodology
2 Executive Summary
3 Global Ureteroscopy Market Overview
3.1 Global Ureteroscopy Market Historical Value (2017-2023)
3.2 Global Ureteroscopy Market Forecast Value (2024-2032)
4 Vendor Positioning Analysis
4.1 Key Vendors
4.2 Prospective Leaders
4.3 Niche Leaders
4.4 Disruptors
5 Global Ureteroscopy Market Landscape*
5.1 Global Ureteroscopy: Developers Landscape
5.1.1 Analysis by Year of Establishment
5.1.2 Analysis by Company Size
5.1.3 Analysis by Region
5.2 Global Ureteroscopy: Product Landscape
5.2.1 Analysis by Type
6 Global Ureteroscopy Market Dynamics
6.1 Market Drivers and Constraints
6.2 SWOT Analysis
6.2.1 Strengths
6.2.2 Weaknesses
6.2.3 Opportunities
6.2.4 Threats
6.3 PESTEL Analysis
6.3.1 Political
6.3.2 Economic
6.3.3 Social
6.3.4 Technological
6.3.5 Legal
6.3.6 Environment
6.4 Porter’s Five Forces Model
6.4.1 Bargaining Power of Suppliers
6.4.2 Bargaining Power of Buyers
6.4.3 Threat of New Entrants
6.4.4 Threat of Substitutes
6.4.5 Degree of Rivalry
6.5 Key Demand Indicators
6.6 Key Price Indicators
6.7 Industry Events, Initiatives, and Trends
6.8 Value Chain Analysis
7 Global Ureteroscopy Market, Epidemiology Snapshot
7.1 Overview of Global Ureteroscopy Incidence Number (2017-2032)
7.2 Incidence Number, By Indication (2017-2032)
7.2.1 Kidney Cancer
7.2.2 Urolithiasis
7.2.3 Urinary Stricture
7.2.4 Others
8 Global Ureteroscopy Market Segmentation (2017-2032)
8.1 Global Ureteroscopy Market (2017-2032) by Type
8.1.1 Market Overview
8.1.2 Flexible Ureteroscopes
8.1.3 Semi-rigid Ureteroscopes
8.1.4 Rigid Ureteroscopes
8.2 Global Ureteroscopy Market (2017-2032) by Application
8.2.1 Market Overview
8.2.2 Kidney Cancer
8.2.3 Urolithiasis
8.2.4 Urinary Stricture
8.2.5 Others
8.3 Global Ureteroscopy Market (2017-2032) by End User
8.3.1 Market Overview
8.3.2 Hospitals
8.3.3 Specialty Clinics
8.3.4 Ambulatory Surgery Centers
8.3.5 Others
8.4 Global Ureteroscopy Market (2017-2032) by Region
8.4.1 Market Overview
8.4.2 North America
8.4.3 Europe
8.4.4 Asia Pacific
8.4.5 Latin America
8.4.6 Middle East and Africa
9 North America Ureteroscopy Market (2017-2032)
9.1 North America Ureteroscopy Market (2017-2032) by Type
9.1.1 Market Overview
9.1.2 Flexible Ureteroscopes
9.1.3 Semi-rigid Ureteroscopes
9.1.4 Rigid Ureteroscopes
9.2 North America Ureteroscopy Market (2017-2032) by Application
9.2.1 Market Overview
9.2.2 Kidney Cancer
9.2.3 Urolithiasis
9.2.4 Urinary Stricture
9.2.5 Others
9.3 North America Ureteroscopy Market (2017-2032) by End User
9.3.1 Market Overview
9.3.2 Hospitals
9.3.3 Specialty Clinics
9.3.4 Ambulatory Surgery Centers
9.3.5 Others
9.4 North America Ureteroscopy Market (2017-2032) by Country
9.4.1 United States of America
9.4.2 Canada
10 Europe Ureteroscopy Market (2017-2032)
10.1 Europe Ureteroscopy Market (2017-2032) by Type
10.1.1 Market Overview
10.1.2 Flexible Ureteroscopes
10.1.3 Semi-rigid Ureteroscopes
10.1.4 Rigid Ureteroscopes
10.2 Europe Ureteroscopy Market (2017-2032) by Application
10.2.1 Market Overview
10.2.2 Kidney Cancer
10.2.3 Urolithiasis
10.2.4 Urinary Stricture
10.2.5 Others
10.3 Europe Ureteroscopy Market (2017-2032) by End User
10.3.1 Market Overview
10.3.2 Hospitals
10.3.3 Specialty Clinics
10.3.4 Ambulatory Surgery Centers
10.3.5 Others
10.4 Europe Ureteroscopy Market (2017-2032) by Country
10.4.1 United Kingdom
10.4.2 Germany
10.4.3 France
10.4.4 Italy
10.4.5 Others
11 Asia Pacific Ureteroscopy Market (2017-2032)
11.1 Asia Pacific Ureteroscopy Market (2017-2032) by Type
11.1.1 Market Overview
11.1.2 Flexible Ureteroscopes
11.1.3 Semi-rigid Ureteroscopes
11.1.4 Rigid Ureteroscopes
11.2 Asia Pacific Ureteroscopy Market (2017-2032) by Application
11.2.1 Market Overview
11.2.2 Kidney Cancer
11.2.3 Urolithiasis
11.2.4 Urinary Stricture
11.2.5 Others
11.3 Asia Pacific Ureteroscopy Market (2017-2032) by End User
11.3.1 Market Overview
11.3.2 Hospitals
11.3.3 Specialty Clinics
11.3.4 Ambulatory Surgery Centers
11.3.5 Others
11.4 Asia Pacific Ureteroscopy Market (2017-2032) by Country
11.4.1 China
11.4.2 Japan
11.4.3 India
11.4.4 ASEAN
11.4.5 Australia
11.4.6 Others
12 Latin America Ureteroscopy Market (2017-2032)
12.1 Latin America Ureteroscopy Market (2017-2032) by Type
12.1.1 Market Overview
12.1.2 Flexible Ureteroscopes
12.1.3 Semi-rigid Ureteroscopes
12.1.4 Rigid Ureteroscopes
12.2 Latin America Ureteroscopy Market (2017-2032) by Application
12.2.1 Market Overview
12.2.2 Kidney Cancer
12.2.3 Urolithiasis
12.2.4 Urinary Stricture
12.2.5 Others
12.3 Latin America Ureteroscopy Market (2017-2032) by End User
12.3.1 Market Overview
12.3.2 Hospitals
12.3.3 Specialty Clinics
12.3.4 Ambulatory Surgery Centers
12.3.5 Others
12.4 Latin America Ureteroscopy Market (2017-2032) by Country
12.4.1 Brazil
12.4.2 Argentina
12.4.3 Mexico
12.4.4 Others
13 Middle East and Africa Ureteroscopy Market (2017-2032)
13.1 Middle East and Africa Ureteroscopy Market (2017-2032) by Type
13.1.1 Market Overview
13.1.2 Flexible Ureteroscopes
13.1.3 Semi-rigid Ureteroscopes
13.1.4 Rigid Ureteroscopes
13.2 Middle East and Africa Ureteroscopy Market (2017-2032) by Application
13.2.1 Market Overview
13.2.2 Kidney Cancer
13.2.3 Urolithiasis
13.2.4 Urinary Stricture
13.2.5 Others
13.3 Middle East and Africa Ureteroscopy Market (2017-2032) by End User
13.3.1 Market Overview
13.3.2 Hospitals
13.3.3 Specialty Clinics
13.3.4 Ambulatory Surgery Centers
13.3.5 Others
13.4 Middle East and Africa Ureteroscopy Market (2017-2032) by Country
13.4.1 Saudi Arabia
13.4.2 United Arab Emirates
13.4.3 Nigeria
13.4.4 South Africa
13.4.5 Others
14 Regulatory Framework
14.1 Regulatory Overview
14.2 US FDA
14.3 EU EMA
14.4 INDIA CDSCO
14.5 JAPAN PMDA
14.6 Others
15 Funding and Investment Analysis
15.1 Analysis by Funding Instances
15.2 Analysis by Type of Funding
15.3 Analysis by Funding Amount
15.4 Analysis by Leading Players
15.5 Analysis by Leading Investors
15.6 Analysis by Geography
16 Strategic Initiatives
16.1 Analysis by Partnership Instances
16.2 Analysis by Type of Partnership and Collaborations
16.3 Analysis by Joint Ventures
16.4 Analysis by Leading Players
16.5 Analysis by Geography
17 Supplier Landscape
17.1 Market Share Analysis, By Region (Top 5 Companies)
17.1.1 Market Share Analysis: Global
17.1.2 Market Share Analysis: North America
17.1.3 Market Share Analysis: Europe
17.1.4 Market Share Analysis: Asia-Pacific
17.1.5 Market Share Analysis: Others
17.2 Storz Medical AG
17.2.1 Financial Analysis
17.2.2 Product Portfolio
17.2.3 Demographic Reach and Achievements
17.2.4 Mergers and Acquisitions
17.2.5 Certifications
17.3 Boston Scientific Corporation
17.3.1 Financial Analysis
17.3.2 Product Portfolio
17.3.3 Demographic Reach and Achievements
17.3.4 Mergers and Acquisitions
17.3.5 Certifications
17.4 Elmed Medical Systems
17.4.1 Financial Analysis
17.4.2 Product Portfolio
17.4.3 Demographic Reach and Achievements
17.4.4 Mergers and Acquisitions
17.4.5 Certifications
17.5 Rocamed
17.5.1 Financial Analysis
17.5.2 Product Portfolio
17.5.3 Demographic Reach and Achievements
17.5.4 Mergers and Acquisitions
17.5.5 Certifications
17.6 Olympus Corporation
17.6.1 Financial Analysis
17.6.2 Product Portfolio
17.6.3 Demographic Reach and Achievements
17.6.4 Mergers and Acquisitions
17.6.5 Certifications
17.7 OTU Medical Inc.
17.7.1 Financial Analysis
17.7.2 Product Portfolio
17.7.3 Demographic Reach and Achievements
17.7.4 Mergers and Acquisitions
17.7.5 Certifications
17.8 Cook Medical
17.8.1 Financial Analysis
17.8.2 Product Portfolio
17.8.3 Demographic Reach and Achievements
17.8.4 Mergers and Acquisitions
17.8.5 Certifications
17.9 Accel Medical
17.9.1 Financial Analysis
17.9.2 Product Portfolio
17.9.3 Demographic Reach and Achievements
17.9.4 Mergers and Acquisitions
17.9.5 Certifications
17.10 Stryker
17.10.1 Financial Analysis
17.10.2 Product Portfolio
17.10.3 Demographic Reach and Achievements
17.10.4 Mergers and Acquisitions
17.10.5 Certifications
18 Global Ureteroscopy Market - Distribution Model (Additional Insight)
18.1 Overview
18.2 Potential Distributors
18.3 Key Parameters for Distribution Partner Assessment
19 Key Opinion Leaders (KOL) Insights (Additional Insight)20 Company Competitiveness Analysis (Additional Insight)

Companies Mentioned

  • Storz Medical AG
  • Boston Scientific Corporation
  • Elmed Medical Systems
  • Rocamed
  • Olympus Corporation
  • OTU Medical Inc.
  • Cook Medical
  • Accel Medical
  • Stryker

Methodology

Loading
LOADING...

Table Information